Abstract
With raising incidence rates, non-small cell lung carcinoma (NSCLC) is the leading cause of death and a major health problem in Latin America. The region faces several challenges to deliver optimal care related to delay in diagnosis, lack of access to biomarker testing and limited access to novel therapies. LATINO Lung is a large observational study describing the current situation of advanced NSCLC in Latin America. We present the first results of patient’s characteristics and diagnostic profiles.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
